MK 0893: Mechanism, Evidence, and Workflow for Glucagon Rece
2026-07-07
MK 0893 is a potent, competitive, and reversible glucagon receptor antagonist studied for type 2 diabetes research. Its unique binding to an extra-helical allosteric site inhibits GCGR activation and cAMP signaling. This article synthesizes current evidence, protocol integration, and practical limits for laboratory and translational workflows.
IWP-2 in Cancer Research: Unraveling Wnt Pathway Dependencie
2026-07-06
Explore how IWP-2, a potent Wnt production inhibitor, uniquely advances cancer research by dissecting Wnt/β-catenin signaling dependencies. This article provides a scientific deep-dive into IWP-2's mechanisms, practical assay considerations, and the latest insights from epigenetics.
Sodium Nitroprusside: Mechanisms and Strategy in Sex-Differe
2026-07-06
Explore how Sodium Nitroprusside, a potent nitric oxide donor, enables translational researchers to dissect sex-specific vascular mechanisms. Drawing on landmark angiotensin II-induced hypertension studies and mechanistic insights, this article provides actionable guidance on experimental design, the evolving competitive landscape, and strategic deployment of NO donors for next-generation cardiovascular research.
HyperScribe™ Poly (A) Tailing Kit: Optimizing mRNA Stability
2026-07-05
The HyperScribe™ Poly (A) Tailing Kit leverages E. coli Poly (A) Polymerase to boost mRNA stability and translation efficiency for advanced gene expression studies. Discover practical protocols and troubleshooting tips that empower researchers to achieve robust, reproducible polyadenylation for transfection, embryo rescue, and therapeutic workflows.
EZ Cap™ Firefly Luciferase mRNA: Optimizing Reporter Assays
2026-07-04
EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure unlocks robust, sustained bioluminescent reporting for gene regulation, mRNA delivery, and in vivo imaging workflows. Its superior capping and poly(A) tail engineering drive enhanced translation and stability, outperforming traditional reporter mRNAs and enabling reliable, high-sensitivity assays across molecular biology applications.
MDV3100 (Enzalutamide): Mechanism and Benchmarks in Prostate
2026-07-03
MDV3100 (Enzalutamide) is a potent second-generation androgen receptor antagonist used in prostate cancer research. It blocks androgen receptor activation, induces apoptosis in AR-amplified cells, and is a benchmark tool for castration-resistant prostate cancer studies. Peer-reviewed evidence and product specifications support its use for AR signaling inhibition workflows.
MRTFA-KCNMB1 Axis Regulates Cancer Cell Stiffness and Metast
2026-07-03
This study uncovers how the MRTFA-KCNMB1 signaling axis modulates cellular stiffness in cancer and its impact on metastatic colonization. By revealing potassium channel-dependent mechanisms that alter cell biomechanics and immune susceptibility, the work identifies new avenues for targeting metastasis through ionic regulation.
Docetaxel in Cancer Chemotherapy Research: Protocols & Insig
2026-07-02
Docetaxel (Taxotere) stands out as a microtubule disassembly inhibitor in advanced cancer chemotherapy research, offering unique advantages in dissecting apoptosis and overcoming drug resistance. This article provides actionable workflows, troubleshooting strategies, and the latest translational findings—including FOXM1-mediated chemoresistance insights—to empower researchers using Docetaxel from APExBIO.
Early Life Adversity Alters Defensive Behavior via Oxytocin
2026-07-02
Tan et al. (2026) demonstrate that early life adversity in mice impairs innate defensive responses to visual threats by disrupting oxytocin signaling within the superior colliculus. This work provides new mechanistic insight into how adverse developmental experiences can rewire neural circuits underlying threat detection, suggesting potential directions for therapeutic intervention.
Caspase-3/7 Inhibitor I: Selective Reversible Caspase-7 Inhi
2026-07-01
Caspase-3/7 Inhibitor I is a highly selective, reversible caspase-7 inhibitor that enables precise modulation of apoptosis in cell-based models. Its nanomolar potency for caspase-3 and -7, cell permeability, and robust selectivity profile make it a benchmark tool for dissecting caspase-dependent signaling pathways and apoptosis inhibition in Jurkat cells.
Isoproterenol Sulfate Dihydrate: Precision Modulation of Hum
2026-07-01
Explore the unique capabilities of Isoproterenol sulfate dihydrate as a precision tool for dissecting human pacemaker maturation and beta-adrenergic receptor signaling. This article provides a deep dive into assay optimization, neuro-cardiac modeling, and translational research advances.
Bergenin Modulates γδT17 Cells via PPARγ-PROX1 in Psoriasis
2026-06-30
This study reveals a novel mechanism by which bergenin, a plant-derived PPARγ agonist from Bergenia purpurascens, ameliorates psoriasis by targeting pathogenic γδT17 cells through PPARγ-mediated ubiquitination and degradation of PROX1. These findings clarify the metabolic and transcriptional regulation of psoriatic inflammation and identify a potential pathway for therapeutic intervention in immune-driven skin diseases.
Modeling Human Pacemaker Maturation with SAN-Plexus Assemblo
2026-06-30
The reference study introduces a human pluripotent stem cell (PSC)-derived assembloid system integrating sinoatrial node (SAN) organoids with cardiac plexus organoids, enabling in vitro modeling of neuron-to-pacemaker interactions. This platform reveals how neuro-cardiac signaling, particularly via PSAP-GPR37, drives pacemaker maturation, offering a high-fidelity model for studying human cardiac conduction and disease.
Pexidartinib (PLX3397) for CSF1R Inhibition in Tumor and CNS
2026-06-29
Pexidartinib (PLX3397) offers unparalleled selectivity for CSF1R, enabling precise modulation of macrophages and microglia within tumor and CNS research models. Its robust nanomolar potency and workflow-driven formulation options make it a leading choice for translational oncology and neuroimmune studies.
3X (DYKDDDDK) Peptide: Precision Epitope Tag for Protein Pur
2026-06-29
The 3X (DYKDDDDK) Peptide, also known as the 3X FLAG peptide, is a synthetic epitope tag enabling high-sensitivity affinity purification and immunodetection of recombinant proteins. Its trimeric, hydrophilic sequence ensures minimal interference with protein structure while allowing robust, antibody-mediated isolation. This dossier provides evidence-based guidance on its mechanism, applications, and experimental boundaries.
464 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page